最新消息

MALAYSIA: MDA/GD/0067: POST MARKET INFORMATION EXCHANGE FOR ASEAN MEMBER STATES – MARCH/APRIL 2024

MALAYSIA: MDA/GD/0067: POST MARKET INFORMATION EXCHANGE FOR ASEAN MEMBER STATES – MARCH/APRIL 2024

  • 2024-04-03 09:34:09

The Medical Device Authority (MDA) published new Guidance Document, on “POST MARKET INFORMATION EXCHANGE FOR ASEAN MEMBER STATES”, on January, 2024. This document serves as guidance on exchange of post market information among AMS.
In order to maintain patient safety and public health, it is necessary that all medical devices that are placed in the market meet appropriate standards of safety, quality and performance, and that they are used safely.

了解更多
INDONESIA: POST MARKET TESTING OF MEDICAL DEVICES – OCTOBER/NOVEMBER 2023

INDONESIA: POST MARKET TESTING OF MEDICAL DEVICES – OCTOBER/NOVEMBER 2023

  • 2023-10-20 07:21:15

In September 2023, a circular letter issued by Indonesia’s Ministry of Health recommended that distributor license owners conduct post-market testing independently on circulated products. Products with submitted independent post-market test results which are within qualifications will receive a priority benefit in the e-Katalog system.

了解更多
USA: 522 Postmarket Surveillance Studies Program

USA: 522 Postmarket Surveillance Studies Program

  • 2021-04-26 02:44:41

The Center for Devices and Radiological Health (CDRH) has established an internal tracking system for 522 postmarket surveillance studies, where each product applicant can view the status and timeline of their products when the FDA requires the 522 postmarket surveillance study.

了解更多
Post-market surveillance Services

Post-market surveillance Services

  • 2020-11-09 10:51:43

Post-market surveillance has become an inexorable trend around the globe.
Therefore, proactively collect and track the following information of your products is essential and crucial.
-Relative post-market incidents reported (e.g. alerts, AEs, recalls)
-Relevant clinical literatures

了解更多